{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-000976","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.140054+00:00","generated_at":"2026-06-07T04:35:36.905535+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Enovis Corp closes acquisition of LimaCorporate for ~€727M cash plus 1.94M shares","bullets":["Completed acquisition of LimaCorporate on Jan 3, 2024 for ~€726.8M cash plus 1,942,686 shares valued at €100M.","Acquisition financed with term loan facility and proceeds from 3.875% convertible senior notes due 2028.","Lima adds 3D-printed Trabecular Titanium implants and comprehensive shoulder revision portfolio.","Enovis' recon segment to reach $1B in revenue, accelerating global growth and margin expansion.","CEO Matt Trerotola highlights strategic acquisition to drive compounding value for shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-000976","json":"https://secwatch.observer/filing/0001193125-24-000976.json","markdown":"https://secwatch.observer/filing/0001193125-24-000976.md","text":"https://secwatch.observer/filing/0001193125-24-000976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000119312524000976/0001193125-24-000976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000119312524000976/d697122d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:35:36.905535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d756dba7e447ede4ee8e4f433cd50a7e49b2fe30","claim":"Enovis CORP completed an acquisition involving Emil Holding II S.à r.l for cash consideration of approximately €726.8 million, which included the repayment of certain Lima indebtedness, transfer taxes and notarial fees, and 1,942,686 s (closed 2024-01-03).","evidence_excerpt":"“Purchase Agreement”) with the Seller, the Company acquired all of the issued and outstanding share capital of Lima from the Seller for (i) cash consideration of approximately €726.8 million, which included the repayment of certain Lima indebtedness, transfer taxes and notarial fees, and (ii) 1,942,686 shares of Enovis common stock, par value $0.001 per share (the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420800/000119312524000976/0001193125-24-000976-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Emil Holding II S.à r.l"},{"label":"Consideration","value":"cash consideration of approximately €726.8 million, which included the repayment of certain Lima indebtedness, transfer taxes and notarial fees, and 1,942,686 s"},{"label":"Closing","value":"2024-01-03"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}